8th Eurasian Uro-oncology Congress
Official Airline
Turkish Airlines is the official airline of “8th Eurasian Uro-oncology Congress” and special discounts are offered on certain booking classes. In order to proceed with the online booking tool for Turkish Conventions please visit the Turkish Conventions website https://www4.thy.com/TKC/app/main?language=en and use the event code “108TKM18” under delegate section.
Best Case Report Contest
Who can participate
Urologists representing national societies of Urology or other institutions who are the official partners of the 8th Eurasian Uro-oncology Congress.
Criteria for submission
- Only original case reports previously unpublished and not under consideration for publication elsewhere may be submitted.
- Case reports should describe an original observation concerning diagnosis, treatment or both. They should fit into one of the following categories:
– Rare conditions.
– Unusual presentation or complications of a relatively common condition.
– A difficult road to diagnosis.
– Cases of high educational value for other reasons.
Rules
1. Cases will be collected by online abstract system.
2. Academic titles should not be used in author names.
3. Summary; purpose, method, findings, conclusions and key words.
4. The abstract must not exceed 250 words, excluding the full title, title, author’s name, surname.
5. The names and addresses of the institutions in which the authors work should be clearly indicated.
Ex: Xxxx University Faculty of Medicine, Xxxx Department of Health, City
6. If an abbreviation is used in the abstract, the abbreviated name of the abbreviation should be specified in parentheses.
7. Deadline for abstract submission: 18 May 2018.
Points to Consider
– If this is the first time you will use the online notification module, you must register with the system using the “New User” link.
– After sign-up, explanations on the page will help you. Read the messages and explanations carefully.
– Keep a confirmation message to your email address after your abstract submission.
– You can follow the entire evaluation process with your email and password through your system.
– For technical support or questions during submission:
LookUs Information Services Ltd.
Tel: (0216) 372 66 44
Invited Speakers
Jean de la Rosette
Academic Medical Center University of Amsterdam, Department of Urology, The Netherlands
Ignacio Duran
Virgen del Rocio University Hospital, Department of Biological Medicine, Spain
Steven Joniau
University Hospital Leuven, Department of Urology, Belgium
Jose A. Karam
The University of Texas MD Anderson Cancer Center, Department of Urology, USA
Makarand Khochikar
Siddhi Vinayak Ganapati Cancer Hospital, India
Badrinath Konety
University of Minnesota, Department of Urology, USA
Omer Kucuk
Winship Cancer Institute of Emory University, Department of Oncology,USA
Pilar Laguna
Academic Medical Center University of Amsterdam, Department of Urology, The Netherlands
Börje Ljungberg
Head of Unit Urology and Andrology, Sweden
Aytekin Oto
The University of Chicago, Department of Urology, USA
Rajeev Sood
Dean of PGI MER & Dr RML Hospital, India
Simon Tanguay
McGill University, Department of Urologic Oncology, Canada
Dogu Teber
Heidelberg University,Department of Urology, Germany

Omer Kucuk
Winship Cancer Institute of Emory University, Department of Oncology,USA
Omer Kucuk, MD, conducted the first clinical trials to show the benefits of soy and lycopene supplements in prostate cancer treatment. He is a Professor in Hematology and Medical Oncology at Emory University’s Winship Cancer Institute.
Dr. Kucuk came to Emory Winship from the Karmanos Cancer Center at Wayne State University in Detroit where he was a professor and co-leader of the population sciences and prevention program and member of genitourinary and head and neck cancer multidisciplinary groups.
Dr. Kucuk has more than 200 peer-reviewed publications, review articles and book chapters to his credit, and he is on the editorial boards of numerous publications, including the Cancer Epidemiology, Biomarkers and Prevention and Cancer Epidemiology.
Nutrition and cancer is Dr. Kucuk’s primary research focus, and he has published extensively on various nutrients in combination with chemotherapy and radiation. Dr. Kucuk has been conducting clinical trials with lycopene and soy isoflavones in combination with standard therapy for prostate cancer since 1995. He is also investigating the effects of micronutrients and phytochemicals on biomarkers of cell growth, differentiation, inflammation and oxidative stress in a variety of cancers.
Dr. Kucuk earned his medical degree at Hacettepe University Medical School in Ankara, Turkey. He conducted a residency and fellowship at St. Francis Hospital in Evanston, Illinois, and a hematology and oncology fellowship at Northwestern University Medical School in Chicago. Before joining the medical staff at Wayne State University, Dr. Kucuk served as professor and researcher at the University of Hawaii’s John A. Burns School of Medicine in Honolulu.

Rajeev Sood
Dean of PGI MER & Dr RML Hospital, India

Makarand Khochikar
Siddhi Vinayak Ganapati Cancer Hospital, India
Dr Makarand Khochikar qualified as a surgeon in 1988 (Miraj), completed his residency in urology in 1992 (Mumbai) and then had further training in urology, urologic oncology at Bedford and Addenbrooke’s hospital, Cambridge (UK) from 1993-1998.He returned to India in 1998 to establish a state of the art Uro-oncology unit at Siddhi Vinayak Ganapati Cancer Hospital, Miraj. This department undertakes large amount of uro-oncological work and has made its presence felt nationally and internationally.
Dr Khochikar has won many awards. Dr Kirpekar award and Gold Medal for standing first in university in Master of Surgery exam in1988, Schering Prize and a Gold medal for standing first at University of London in Dip.Urol exam in 1991, Vijayawada Best poster award and Brijkishor Patana best paper award are some of them. Recently he was awarded the highest honor of urological society of India (West Zone) – The Urology Gold Medal in 2010. Recipient of Gold Medal and SLAUS oration by Sri Lanka Urology Association in 2011. In year 2012- he was awarded yet another prestigious award – Pinamaneni Oration and Gold medal by USI for his life time work on adrenal tumors mainly pheochromocytoma. He has one of the largest individual series on adrenal tumors in India. He was awarded the best reviewer’s award – special appreciation by Indian Journal of Urology for 2015.
He has produced many high quality original publications; review articles in peer reviewed national and international journals and contributed in book chapters.
Has been invited as a national and international faculty to many centers, has conducted large number of symposia, operative demonstrations and delivered guest lecturers across the globe. Teaching has been very close to his heart, has been conducting teaching courses on Uro-oncology since last 15 years, a weeklong crash course on Uro-oncology conducted annually at Muljibhai Patel urological hospital, Nadiyad and JPAC is the most popular course in urology in India.
He has conducted teaching courses for Asian School of Urology and SUA at Singapore, BAUS and ASU at Bangladesh, European School of Urology and ASU at Hong Kong, Malaysia, Sri Lanka and Indonesia. He has been part of AUA -USI instructional courses in India and has conducted instructional courses at SIU annual meetings. Recently he conducted a three day course on Uro-oncology at Nadiyad which was webcasted by SIU academy.
Has been invited as a guest speaker for many international meetings ( AUA ,SIU , EAU,WPCC , WUOF , BAUS ) and by international societies in Asia ( India , Sri Lanka , Bangladesh, Malaysia, Hong Kong, Singapore, Indonesia, China, Philippines, Myanmar), Japan ,Australia, UK , Germany, Italy , France, Spain , Greece ,Middle East ,UAE ,Egypt ,USA and Canada in last twenty years.
He was the core member of the Guidelines committee that designed Indian Bladder Cancer Guidelines for Urological society of India. He was the member of the Indian panel that recommended amendments in TNM classification system for urological cancers in 2004.He was on the panel for the Melbourne Prostate Cancer statement, at WPCC meeting in Australia in 2014.
Was invited as an examiner for exit exam in urology at Singapore and for P hD at Pravara University, Pravaranagar (India)
Dr Khochikar was a member of the ICUD (International Consultation on Urologic Diseases) consultation panel for upper tract TCC supported by SIU and is also currently involved in preparing ICUD –SIU guidelines on bladder cancer .
Dr Khochikar served on editorial board of Indian Journal of Urology (2000-2009), Current Urology Reports, and peer reviewer for BJUI, Journal of Urology, Indian Journal of surgery, Indian Journal of cancer, Urology Annals, International Journal of Urology, Journal of Clinical Urology and many others. He has served as a guest editor of the special issue of IJU on hormone refractory prostate cancer. He did undertake the course for the reviewers by Journal of Urology.
He has served as a council member of Urological society of India (USI), USI-West Zone, was a core member of education cell of USI and has served as a convener of research cell of USI. He was the convener of the section of uro-oncology for the USI (2003-2007)
He is currently National delegate for the Indian section of SIU, has served as Deputy National Delegate from 2013-2015.He has been appointed as Board of Directors of SIU in Oct 2016.
He is currently President of the Urological society of India –West zone .
Currently he is the Chairman of the Department of Uro-oncology at Siddhi Vinayak Ganapati Cancer Hospital, Miraj and is also a member of the management committee and Governing council of the hospital.
Considered as an authority and leading surgeon in India in Nephron sparing surgery, Radical prostatectomy, and radical cystectomy with neobladder reconstruction in bladder cancer, adrenalectomies and post chemotherapy RPLND in testicular cancer.

Steven Joniau
University Hospital Leuven, Department of Urology, Belgium

Börje Ljungberg
Head of Unit Urology and Andrology, Sweden

Badrinath Konety
University of Minnesota, Department of Urology, USA

Simon Tanguay
McGill University, Department of Urologic Oncology , Canada

Jean de la Rosette
Academic Medical Center University of Amsterdam, Department of Urology, The Netherlands

Ignacio Duran
Virgen del Rocio University Hospital, Department of Biological Medicine, Spain

Jose A. Karam
The University of Texas MD Anderson Cancer Center, Department of Urology, USA
Dr. Karam is an Associate Professor of Urology at MD Anderson Cancer Center. He is certified by the American Board of Urology, and provides surgical care for patients with renal, testicular and adrenal tumors. He performs open, laparoscopic, and robotic surgery, with a special interest in surgery for locally advanced and locally recurrent disease.
Dr. Karam earned his medical degree with Distinction from the American University of Beirut. He completed Urology residency at UT Southwestern Medical Center, followed by a Urologic Oncology Fellowship at MD Anderson Cancer Center.
Dr. Karam’s primary clinical and research interest is renal cell carcinoma, including the integration of targeted therapy with surgery (adjuvant, neoadjuvant, and presurgical therapy), sarcomatoid renal cell carcinoma, rare kidney cancer histologies including renal medullary carcinoma, mouse models of renal cell carcinoma and molecular markers. He has authored more than 170 articles and book chapters in urologic oncology. He serves as a reviewer for over 20 journals, and is an Editorial Board member of BJU International, Section Editor for Annals of Surgical Oncology, and Associate Editor for Frontiers in Oncology.

Pilar Laguna
Academic Medical Center University of Amsterdam, Department of Urology, The Netherlands

Aytekin Oto
The University of Chicago, Department of Urology, USA
Dr. Oto is the Vice Chair for Business Development, Chief of Abdominal Imaging and Body MRI at the University of Chicago, and has a wide range of experience and expertise in the imaging of diseases affecting abdomen and pelvis. His interest focus is development and clinical application of novel prostate MRI acquisition and interpretation so as to facilitate and improve the efficiency of prostate cancer and develop image guided prostate therapy options for the appropriate patients diagnosed with prostate cancer. His research has resulted in more than 150 publications and over 150 scientific exhibits at national and international meetings. The two overarching aims of his research are: 1) non-invasive and accurate diagnosis of aggressive prostate cancer using MR imaging; and 2) eradication of localized prostate cancer with minimal complications using minimally invasive treatment methods. Our group has already has developed new MR sequences, pilot CAD software for prostate MRI, and tested MR guided therapy methods such as laser and focused ultrasound ablation in clinical and pre-clinical studies.

Dogu Teber
Heidelberg University,Department of Urology, Germany
Faculty
Oztug Adsan
TOBB-ETU Hospital, Department of Urology, Turkey
Erdem Akbay
Mersin University Faculty of Medicine, Department of Urology, Turkey
Ziya Akbulut
Istanbul Medipol University Faculty of Medicine, Department of Urology, Turkey
Oktay Akca
U.H.S. Istanbul Kartal Dr. Lütfi Kırdar Training and Research Hospital, Department of Urology, Turkey
Farkhad Akilov
President of Scientific Society of Urology of Uzbekistan, Uzbekistan
Yigit Akin
Izmir Katip Celebi University Faculty of Medicine, Department of Urology, Turkey
Selami Albayrak
Medipol University Hospital Faculty of Medicine, Department of Urology, Turkey
Fatih Altunrende
U.H.S. Okmeydanı Training and Research Hospital, Department of Urology, Turkey
Murat Arslan
İzmir Medical Park Hospital, Department of Urology, Turkey
Yilmaz Arslan
U.H.S. Ankara Numune Training and Research Hospital, Department of Urology, Turkey
Ali Fuat Atmaca
Ankara Yildirim Beyazit University Faculty of Medicine, Department of Urology, Turkey
Khaled Attallah
President of Tunisian Urological Society, Tunisia
Fatih Atug
Istanbul Florence Nightingale Hospital, Department of Urology, Turkey
Sabahattin Aydin
Rector of Istanbul Medipol University, Turkey
Ali Ayyildiz
U.H.S. Ankara Training and Research Hospital, Department of Urology, Turkey
Hasan Bakirtas
Memorial Ankara Hospital, Department of Urology, Turkey
M. Derya Balbay
Koc University School of Medicine, Department of Urology, Turkey
Halil Basar
U.H.S. Ankara Oncology Training and Research Hospital, Department of Urology, Turkey
Abbas Basiri
President of Iranian Urological Association, Iran
Erem Kaan Basok
Izmir Medical Park Hospital, Department of Urology, Turkey
Zeki Bayraktar
Istanbul Medipol University Faculty of Medicine, Department of Urology, Turkey
Hale Caglar
Anadolu Medical Center, Department of Radiation Oncology, Turkey
Meltem Caglar Tuncalı
Hacettepe University Faculty of Medicine, Department of Nuclear Medicine, Turkey
Omer Onur Cakir
U.H.S. Bagcilar Training and Research Hospital, Department of Urology, Turkey
A. Erdem Canda
Yildirim Beyazit University Faculty of Medicine, Department of Urology, Turkey
Turhan Caskurlu
Istanbul Medeniyet University Faculty of Medicine, Department of Urology, Turkey
Mustafa Cengiz
Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Turkey
Archil Chkhotua
Secretary General of Georgian Urological Association, Georgia
Jean de la Rosette
Academic Medical Center University of Amsterdam, Department of Urology, The Netherlands
Abdullah Demirtas
Erciyes University Faculty of Medicine, Department of Urology, Turkey
Ozdal Dillioglugil
Kocaeli University Faculty of Medicine, Department of Urology, Turkey
Cetin Dincel
U.H.S. Bozyaka Research and Training Hospital, Department of Urology, Turkey
Ignacio Duran
Virgen del Rocio University Hospital, Department of Biological Medicine, Spain
Selcuk Erdem
Istanbul University Faculty of Medicine, Department of Urology, Turkey
Bulent Erkurt
Istanbul Medipol University Faculty of Medicine, Department of Urology, Turkey
Cengiz Erol
Istanbul Medipol University Faculty of Medicine, Department of Radiology, Turkey
Sakıp Erturhan
Gaziantep University Faculty of Medicine, Department of Urology, Turkey
Tarik Esen
Koc University School of Medicine, Department of Urology, Turkey
Ismail Evren
U.H.S. Dr. Sadi Konuk Bakirkoy Research and Training Hospital, Department of Urology, Turkey
Arnaldo Figueiredo
Coimbra University Hospital, Department of Urology, Portugal
Cankon Germiyanoglu
Ondokuz Mayıs University Faculty of Medicine, Department of Urology, Turkey
Arthur M. Grabsky
President of Armenian Association of Urology, Armenia
Alexander Greenstein
President of Israel Urological Association, Israel
Mehmet Gulluoglu
Head of AFAD, Turkey
Eyup Gumus
Undersecretary of Republic of Turkey Ministry of Health, Turkey
Mahmut Gumus
President of Turkish Society of Medical Oncology, Turkey
Cenk Gurbuz
Medistate Hospital, Department of Urology, Turkey
Recai Gurbuz
Bezmialem Vakif University Faculty of Medicine Hospital, Department of Urology, Turkey
Zafer Gokhan Gurbuz
U.H.S. Adana Numune Training and Research Hospital, Department of Urology, Turkey
Selcuk Guven
Istanbul Medipol University Faculty of Medicine, Department of Urology, Turkey
Rahim Horuz
Istanbul Medipol University Faculty of Medicine, Department of Urology, Turkey
Musab Ilgi
U.H.S. Istanbul Sisli Hamidiye Etfal Training and Research Hospital, Department of Urology, Turkey
Abdurrahim Imamoglu
U.H.S. Diskapi Yildirim Beyazit Training and Research Hospital, Department of Urology, Turkey
Vasif Ismayil
Azerbaijan Medical University, Department of Urology, Azerbaijan
Steven Joniau
University Hospital Leuven, Department of Urology, Belgium
Levent Kabasakal
Istanbul University Cerrahpasa Faculty of Medicine, Department of Nuclear Medicine, Turkey
Ates Kadioglu
Istanbul University Istanbul Faculty of Medicine, Department of Urology, Turkey
Bunyamin Kaplan
Istanbul Medipol University Faculty of Medicine, Department of Radiation Oncology, Turkey
Jose A. Karam
The University of Texas MD Anderson Cancer Center, Department of Urology, USA
M. Ihsan Karaman
Rector of Istanbul Medeniyet University, Turkey
Mehmet Kaynar
Selcuk University Faculty of Medicine, Department of Urology, Turkey
Sarp Korcan Keskin
Bahcesehir University School of Medicine, Department of Urology, Turkey
Bekir Keskinkilic
Turkish Public Health Institution, Vice President, Turkey
Mansur Khalilov
Azerbaijan Medical University, Department of Urology, Azerbaijan
Makarand Khochikar
Siddhi Vinayak Ganapati Cancer Hospital, India
Murat Can Kiremit
Koc University Hospital, Department of Urology, Turkey
Esengul Kocak
Medipol University Hospital, Department of Radiation Oncology, Turkey
Izzet Kocak
Adnan Menderes University Faculty of Medicine, Department of Urology, Turkey
Badrinath Konety
University of Minnesota, Department of Urology, USA
Fatih Kose
Baskent University Faculty of Medicine, Department of Medical Oncology, Turkey
Eyup Veli Kucuk
U.H.S. Umraniye Training and Research Hospital, Department of Urology, Turkey
Omer Kucuk
Winship Cancer Institute of Emory University, Department of Oncology, USA
Ali Riza Kural
President of Endourological Society, Turkey
Pilar Laguna
Academic Medical Center University of Amsterdam, Department of Urology, The Netherlands
Börje Ljungberg
Head of Unit Urology and Andrology, Sweden
Ahmet Yaser Muslumanoglu
Director of U.H.S. Bağcılar Training and Research Hospital, Turkey
Ismet Nane
Istanbul University Istanbul Faculty of Medicine, Department of Urology, Turkey
Janek Nawrocki
Haywards Heath Hospital, Department of Urology, England
Baris Nuhoglu
Istanbul Yeni Yuzyil University Faculty of Medicine, Department of Urology, Turkey
Oner Odabas
U.H.S. Turkiye Yuksek Ihtisas Training and Research Hospital, Department of Urology, Turkey
Tayfun Oktar
Istanbul University Istanbul Faculty of Medicine, Department of Urology, Turkey
Aytekin Oto
The University of Chicago, Department of Radiology, USA
Kubra Ozgok
U.H.S. Gulhane Research and Training Hospital, Department of Underwater Medicine, Turkey
Yasar Ozgok
President of ILRSA, Turkey
Mustafa Ozguroglu
Istanbul University Cerrahpasa Faculty of Medicine, Department of Medical Oncology, Turkey
Mehmet Serkan Ozkent
Necmettin Erbakan University Meram Faculty of Medicine, Department of Urology, Turkey
Ahmet Ozturk
Necmettin Erbakan University Meram Faculty of Medicine, Department of Urology, Turkey
Emre Can Polat
U.H.S. Okmeydani Training and Research Hospital, Department of Urology, Turkey
Iraklis Poulias
President of Hellenic Urological Association, Greece
Mohammad Hadi Radfar
Shahid Beheshti University of Medical Sciences Labbafinejad Hospital, Department of Urology, Iran
Esra Saglam
Memorial Sisli Hospital, Department of Radiation Oncology, Turkey
Selcuk Sahin
U.H.S. Dr. Sadi Konuk Training and Research Hospital, Department of Urology, Turkey
M. Oner Sanli
Istanbul University Faculty of Medicine, Department of Urology, Turkey
M. Selcuk Silay
Istanbul Medeniyet University Faculty of Medicine, Department of Urology, Turkey
Atilla Semercioz
U.H.S. Bagcilar Training and Research Hospital, Department of Urology, Turkey
Bulat Shalekenov
Chairman of Kazakhstan Association of Men’s Health, Kazakhstan
Abdul Naser Shunaigat
President of Jordanian Association of Urological Surgeons, Jordan
Giray Sonmez
Necmettin Erbakan University Faculty of Medicine, Department of Urology, Turkey
Rajeev Sood
Dean of PGI MER & Dr RML Hospital, India
Tarkan Soygur
Ankara University Faculty of Medicine, Department of Urology, Turkey
Mustafa Soytas
U.H.S. Dr. Sadi Konuk Training and Research Hospital, Department of Urology, Turkey
Simon Tanguay
McGill University, Department of Urologic Oncology , Canada
Ali Ihsan Tasci
Dean of University of Health Sciences Faculty of Medicine, Turkey
Dogu Teber
Heidelberg University, Department of Urology, Germany
Dilek Telci
Yeditepe University Faculty of Engineering, Genetics and Bioengineering Department, Turkey
Ilter Tufek
Acibadem Maslak Hospital, Department of Urology, Turkey
Volkan Tugcu
U.H.S. Dr. Sadi Konuk Bakirkoy Research and Training Hospital, Department of Urology, Turkey
Lutfi Tunc
Gazi University Faculty of Medicine, Department of Urology, Turkey
Omer Levent Tuncay
Pamukkale University Faculty of Medicine, Department of Urology, Turkey
Altug Tuncel
U.H.S. Ankara Numune Training and Research Hospital, Department of Urology, Turkey
Ahmet Tuncay Turgut
Hacettepe University Faculty of Medicine, Department of Radiology, Turkey
Kadir Turkolmez
Ankara University Faculty of Medicine, Department of Urology, Turkey
Taha Ucar
Istanbul Medeniyet University Faculty of Medicine, Department of Urology, Turkey
Dogan Unal
U.H.S. Ankara Oncology Training and Research Hospital, Department of Oncology, Turkey
Ali Unsal
Gazi University Faculty of Medicine Hospital, Department of Urology, Turkey
Ahmet Urkmez
U.H.S. Haydarpasa Numune Training and Research Hospital, Department of Urology, Turkey
Akilbek Cholponkulovich Usupbaev
President of Urology Association of Kyrgyzstan, Kyrgyzstan
Omer Erol Uzel
Istanbul Medipol University Faculty of Medicine, Department of Radiation Oncology, Turkey
Onder Yaman
Ankara University Faculty of Medicine, Department of Urology, Turkey
Ismet Yavascaoglu
Uludag University Medical Faculty, Department Chair, Department of Urology, President of the Endourology Society, Turkey
Faruk Yencilek
Yeditepe University Faculty of Medicine, Department of Urology, Turkey
Asif Yildirim
Istanbul Medeniyet University Faculty of Medicine, Department of Urology, Turkey
Ugur Yucetas
U.H.S. Istanbul Training and Research Hospital, Faculty of Urology, Turkey
Emrah Yuruk
U.H.S. Bagcilar Training and Research Hospital, Department of Urology, Turkey
Scientific Program
June 28th, 2018 | ||
Friends of Georgia |
Location: Main Hall |
|
---|---|---|
08.00 – 10.15 | Bladder Cancer – Part I | |
08.00 – 08.15 | Incidence and mortality of bladder cancer in the world. | |
08.15 – 08.45 | Genomic classification of bladder cancer – NMIBC – MIBC |
|
08.45 – 09.00 | Optical enhancement of NMIBC: An update | |
09.00 – 09.15 | BCG failures: Definitions, management, outcomes | |
09:15 – 09.30 | Follow-up in non-muscle invasive bladder cancer: What is the ideal? | |
09.30 – 09.45 | Gender specific differences in bladder cancer | |
09.45 – 10.15 | Panel: Challenging cases in bladder cancer | |
10.15 – 10.30 | Coffee Break | |
10.30 – 12.15 | Bladder cancer – Part II | |
10.30 – 11.00 | Minimally invasive radical cystectomy: It is worth to do? – Yes – No |
|
11.00 – 11.15 | The potential role of sex steroids and their specific receptors in bladder cancer | |
11.15 – 11.30 | Frailty and bladder cancer | |
11.30 – 12.00 | Systemic treatment in metastatic disease – Chemotherapy – Immunotherapy |
|
11.30 – 11.45 | The role of surgery in metastatic bladder cancer | |
11.45 – 12.15 | Panel: Challenging cases in bladder cancer | |
12.15 – 13.15 | Lunch | |
|
||
B2B Renal Cancer |
Location: Main Hall |
|
13.15 – 14.50 | Mechanism and Biology- Prevention and Diagnosis | |
13.15 – 13.20 | Introduction | |
13.20 – 13.35 | Integrative design for cancer prevention and therapy | |
13.35 – 13.50 | Rationale for renal biopsy | |
13.50 – 14.05 | Implications of next generation sequencing for renal cancer – Liquid biopsy | |
14.05 – 14.20 | Novel diagnostics and surgical interventions – Clinical Integration and Translation | |
14.20 – 14.35 | Frequent incidental diagnosis of small indolent cancers -active surveillance- | |
14.35 – 14.50 | Cystic tumors- challenges | |
14.50 – 15.15 | Coffee Break | |
15.15 – 17.15 | Biology and Engineering- Diagnosis and Treatment | |
15.15 – 15.30 | Image guided minimally invasive procedures – Focal | |
15.30 – 15.45 | Stereotactic ablative radiotherapy for primary renal cancer | |
15.45 – 16.00 | Discussion | |
16.00 – 16.15 | Locally advanced-high risk renal cell carcinoma in the neoadjuvant/adjuvant therapy ARENA | |
16.15 – 16.30 | Experimental and near term future -molecular imaging- | |
16.30 – 16.45 | Immunogenomics -RCC Integrating immunotherapy with the existing drugs- | |
16.45 – 17.00 | Protein-level biomarkers in determining the prognosis and in developing treatment strategies | |
17.00 – 17.15 | Which direction in diagnosis and treatment are we heading? My vision | |
|
||
Workshop |
||
17.00 – 18.00 | Course-1 |
Location: Room 2 |
June 29th, 2018 | ||
08.00 – 09.00 | Opening Remarks | |
Perspectives |
Location: Main Hall |
|
---|---|---|
09.00 – 10.00 | Localised Disease | |
09.00 – 09.15 | When biopsy with mp-MRI? | |
09.15 – 09.30 | mp-MRI in Active Surveillance | |
09.30 – 09.45 | Stereotactic radiotherapy for localized prostate cancer | |
09.45 – 10.00 | Focal therapy: From patient selection to outcomes | |
10.00 – 11.00 | Locally Advanced-Oligometastatic | |
10.00 – 10.15 | Imaging in locally advanced and oligometastatic prostate cancer | |
10.15 – 10.30 | Urologist Perspective | |
10.30 – 10.45 | Radiation oncologist perspective | |
10.45 – 11.00 | Regional LNs in prostate cancer: All aspects | |
11.00 – 11.30 | Coffee Break | |
11.30 – 12.30 | Metastatic Disease – Castration-Resistant Prostate Cancer | |
11.30 – 11.45 | PSMA based imaging and radioligand treatment | |
11.45 – 12.00 | What Combination Drugs with Radium-223 Are Best for Treating Prostate Cancer? | |
12.00 – 12.15 | Conundrums in CHAARTED, LATITUDE and STAMPEDE clinical trials | |
12.15 – 12.30 | Changing role of agents targeting adrenal androgen synthesis. | |
12.30 – 14.00 | Lunch | |
14.00 – 15.00 | Panel: Role of local radiation therapy/surgery in metastatic setting | |
15.00 – 16.00 | Panel: Rising PSA treated with Radiotherapy/ Radical Prostatectomy | |
16.00 – 16.30 | Coffee Break | |
16.30 – 17.45 | Regional Societies Session | |
16.30 – 16.45 | Immigrants: How to provide care for each patient? | |
16.45 – 17.00 | WHO perspective | |
17.00 – 17.15 | Racial/Ethnic/Socioeconomic Disparities (AD/Targeted/Chemo) | |
17.15 – 17.30 | Cancer stage distribution in the immigrant and host populations | |
17.30 – 17.45 | Genetic variants in different populations | |
17.30 – 17.45 | EBU beyond Europe | |
Young UrooncologistsResidents Meet Masters |
Location: Room 2 |
|
16.00-16.50 | Opportunities | |
16:00-16:10 | Residency training and development in TAU | |
16:10-16.20 | Residency training and development in USA | |
16:20-16:30 | Residency training and development in EAU | |
16:30-16:40 | Residency training and development in SIU | |
16:40-16:50 | What is EUA planning for the residents? | |
17.00-18.00 | Education | |
17:00-17:15 | Fundamentals of laparoscopy and education of residents | |
17:15-17:30 | Fundamentals of Robotic Urology and Resident education | |
17:30-17:45 | How to Write a paper? | |
17:45-18:00 | The path, residency to mastership | |
Stay Connected |
Location: Room 6 |
|
16.00-18.00 | Stay Connected | |
Prostate Cancer | ||
Bladder Cancer | ||
Testis Tumors | ||
UTT | ||
Renal Cancer | ||
Workshop |
||
16.00 – 18.00 | Course-2 |
Location: Room 3 |
16.00 – 18.00 | Course-3 |
Location: Room 4 |
16.00 – 18.00 | Course-4 |
Location: Room 5 |
June 30th, 2018 | ||
Perspectives |
Location: Main Hall |
|
---|---|---|
08.00 – 09.30 | Localised Renal Cancer | |
08.00 – 08.15 | Modern Imaging of Renal Tumors | |
08.15 – 08.30 | The Role of Lymph Node Dissection in the Management of Renal Cell Carcinoma | |
08.30 – 09.30 | Adjuvant Therapy for RCC – Current situation and upcoming trials | |
09.30 – 10.15 | Oligometastastic – Metastatic Disease | |
09.30 – 09.45 | What should be the next step? | |
09.45 – 10.00 | Late-Relapse mRCC | |
10.00 – 10.15 | Absence of complete response | |
10.15 – 10.30 | Coffee Break | |
10.30 – 11.30 | Panel: Muscle invasive bladder cancer Radical cytectomy Chemotherapy Bladder preservation strategies |
|
11:30 – 12:05 | Session | |
11.30 – 11.45 | UTT: New Standards | |
11.45 – 12.05 | The Endourological Society President’s Lecture | |
12.05 – 13.00 | Lunch | |
13.00 – 14.00 | Pediatric Urooncology Update: Case-Based Panel Discussion | |
14.00 – 15.00 | Disasters of Masters | |
AS – LIVE |
Location: Main Hall |
|
15.00 – 15.20 | Image guided surgery prostate/kidney | |
15.20 – 15.40 | Perineal Prostatectomy | |
15.40 – 16.00 | Robotic Assisted Perineal Prostatectomy | |
16.00 – 16.20 | UTT endoscopic management | |
16.20 – 16.40 | UTT endoscopic management | |
16.40 – 16.50 | RALP in large prostates | |
16.50 – 17.00 | Blader Cancer –enucleation- | |
17.00 – 17.40 | Partial Nephrectomy Clampless – Yes – No |
|
Urooncology |
Location: Room 1 |
|
15:00 – 15:45 | Advanced Bladder Cancer | |
15.00 – 15.15 | Immunotherapy in Bladder Cancer: Update | |
15.15 – 15.30 | Chemotherapy moving forward in combination with immunotherapy | |
15.30 – 15.45 | Bladder Cancer BioMarkers: Optimal Utilization for Diagnosis and Recurrence | |
Workshop |
||
16.00 – 18.00 | Course-5 |
Location: Room 2 |
16.00 – 18.00 | Course-6 |
Location: Room 3 |
July 1st, 2018 | ||
08.00 – 09.00 | Take home messages |
Location: Main Hall |
General Information
Congress Name
8th Eurasian Uro-oncology Congress
Date
June 28th – July 1st, 2018
Congress Language
Turkish-English (Simultaneous translation will be available)
Venue
The Biltmore Hotel Tbilisi – Georgia
Certificates
Certificate of participation will be given to participants on June 30, 2018 through registration desks at congress center.
Badges
The name badges must be worn at all times to access the sessions, social events. The participant, who have pre-registered, will be able to get their prepared badges and other documents during pre-registration without waiting. After completing the registration process, participants can take their badges..
Invitation
At the request of the participants, the official invitation letter will be sent by the Organizing Committee of the Congress.